MEREO BIOPHARMA GROUP PL-ADR (MREO) Institutional Ownership and Insiders Activity

MEREO BIOPHARMA GROUP PL-ADR (MREO) is widely held by institutional investors, with 54 firms reporting positions valued at approximately $17.99M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Rubric Capital Management Lp is the largest disclosed holder, reporting approximately $4.86M in MREO holdings in its latest filing.